Ikarian Capital »

Sagimet Biosciences Inc-a shares owned by Ikarian Capital

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 388k 2.77
2024-06-30 $1.4M 413k 3.42
2024-03-31 $2.2M 413k 5.42

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
NEA Management Company
Blue Owl Capital Holdings
Baker Bros. Advisors
Alyeska Investment Group
Citadel Advisors
Vanguard Group
BlackRock
BlackRock
Rock Springs Capital Management
Hillhouse Capital Advisors
Siren
Partner Fund Management
Bank of America Corporation
Ikarian Capital

View all funds holding Sagimet Biosciences Inc-a